🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 156944100
- IPO
- 1/25/2024 · $19.00/share
Business: CG Oncology, Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.
Company Contact
- CEO
- Arthur Kuan
- CFO
- Corleen Roche
- Headquarters
- 400 Spectrum Center Drive, Suite 2040, Irvine, CA 92618
- Phone
- 949-409-3700
- Investor Relations
- Bing Kung · bd@cgoncology.com